[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2020[J]. CA Cancer J Clin, 2020,70:7-30. [2] Walsh TJ, Grady RW, Porter MP, et al. Incidence of testicular germ cell cancers in U.S. children: SEER program experience 1973 to 2000[J]. Urology, 2006,68:402-405. [3] Skakkebaek N. Possible carcinoma-in-situ of the testis[J]. Lancet, 1972,300:516-517. [4] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69:7-34. [5] Nicholson BD, Jones NR, Protheroe A, et al. The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: a diagnostic test accuracy systematic review[J]. Cancer Epidemiol, 2019,59:15-21. [6] Domenico M, Giuseppe G, Federica V, et al. Proteomics for the identification of biomarkers in testicular cancer-review[J]. Front Endocrinol, 2019,10:462. [7] Esposito F, Boscia F, Franco R, et al. Down-regulation of oestrogen receptor-β associates with transcriptional co-regulator PATZ1 delocalization in human testicular seminomas[J]. J Pathol, 2011,224:110-120. [8] 王站, 张玉石. Pyk2与肿瘤关系的研究进展[J]. 基础医学与临床, 2019,39:585-588. [9] 董德鑫, 李汉忠. 荧光原位杂交技术在泌尿系统非尿路上皮肿瘤的研究进展[J]. 基础医学与临床, 2011, 31:843-846. [10] Goldberg H, Klaassen Z, Chandrasekar T, et al. Germ cell testicular tumors-contemporary diagnosis, staging and management of localized and advanced disease[J]. Urology, 2019,125:8-19. [11] Cheng L, Albers P, Berney DM, et al. Testicular Cancer[J]. Nat Rev Dis Primers, 2018,4:29. [12] Fung C, Dinh PJR, Ardeshir-Rouhani-Fard S, et al. Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors[J]. Adv Urol, 2018.doi:10.1155/2018/8671832.eCollection2018. [13] Tabakin AL, Shinder BM, Kim S, et al. Retroperitoneal lymph node dissection as primary treatment for men with testicular seminoma: utilization and survival analysis using the national cancer data base, 2004-2014[J]. Clin Genitourin Cancer, 2020,18:e194-e201. |